Ani Pharmaceuticals reported $8.01M in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Aerie Pharmaceuticals AERI:US $ -32.04M 85.4M
Aurora Cannabis Inc ACB:CN -88561000 17.03M
Canopy Growth Corp WEED:CN C$ -273741000 191.85M
Emergent Biosolutions EBS:US $ 37.3M 311M
Endo International Ordinary Shares ENDP:US $ 226.56M 52.35M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Hikma Pharmaceutical HIK:LN 369M 11M
Nektar Therapeutics NKTR:US $ -109.47M 0.5M
Novartis NVS:US $ 4552M 346M
Sun Pharmaceuticals SUNP:IN IR 26169.2M 893.7M
Teva Pharmaceutical TEVA:IT 1.11B 176M
Teva Pharmaceutical Industries TEVA:US $ 1112M 176M